Kevin Rouault‐Pierre

1.8k total citations
36 papers, 1.2k citations indexed

About

Kevin Rouault‐Pierre is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Kevin Rouault‐Pierre has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 15 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Kevin Rouault‐Pierre's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and RNA Research and Splicing (5 papers). Kevin Rouault‐Pierre is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (10 papers) and RNA Research and Splicing (5 papers). Kevin Rouault‐Pierre collaborates with scholars based in United Kingdom, France and United States. Kevin Rouault‐Pierre's co-authors include Dominique Bonnet, François Lassailly, Fernando Anjos‐Afonso, John G. Gribben, Ander Abarrategi, Irene Pizzitola, Diana Passaro, Katie Foster, Orietta Spinelli and Andrea Biondi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kevin Rouault‐Pierre

35 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kevin Rouault‐Pierre 535 500 330 328 173 36 1.2k
Fotis Asimakopoulos 433 0.8× 527 1.1× 326 1.0× 542 1.7× 189 1.1× 40 1.2k
Keegan Barry-Holson 458 0.9× 516 1.0× 442 1.3× 399 1.2× 134 0.8× 10 1.2k
Frédéric Barabé 407 0.8× 719 1.4× 339 1.0× 273 0.8× 127 0.7× 38 1.2k
Enkhtsetseg Purev 529 1.0× 744 1.5× 298 0.9× 721 2.2× 181 1.0× 55 1.6k
Philippe Quittet 735 1.4× 413 0.8× 453 1.4× 493 1.5× 169 1.0× 49 1.6k
Jana Krošl 766 1.4× 1.3k 2.6× 426 1.3× 425 1.3× 186 1.1× 38 2.1k
Catherine Frelin 337 0.6× 698 1.4× 313 0.9× 346 1.1× 299 1.7× 19 1.2k
Binje Vick 245 0.5× 526 1.1× 303 0.9× 455 1.4× 89 0.5× 32 1.0k
Francesco Paolo Tambaro 288 0.5× 770 1.5× 184 0.6× 292 0.9× 158 0.9× 39 1.3k
Allison Mayle 458 0.9× 779 1.6× 199 0.6× 138 0.4× 172 1.0× 13 1.1k

Countries citing papers authored by Kevin Rouault‐Pierre

Since Specialization
Citations

This map shows the geographic impact of Kevin Rouault‐Pierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Rouault‐Pierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Rouault‐Pierre more than expected).

Fields of papers citing papers by Kevin Rouault‐Pierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Rouault‐Pierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Rouault‐Pierre. The network helps show where Kevin Rouault‐Pierre may publish in the future.

Co-authorship network of co-authors of Kevin Rouault‐Pierre

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Rouault‐Pierre. A scholar is included among the top collaborators of Kevin Rouault‐Pierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Rouault‐Pierre. Kevin Rouault‐Pierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chowdhury, Onima, et al.. (2025). Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients. HemaSphere. 9(3). e70103–e70103.
2.
Rouault‐Pierre, Kevin. (2024). Succinyl-coenzyme A: a key metabolite and succinyl group donor in erythropoiesis. Haematologica. 110(2). 276–277. 1 indexed citations
3.
Philippe, Céline, Loïc Van Den Berghe, Marina Bousquet, et al.. (2024). Pivotal role of the endoplasmic reticulum stress-related XBP1s/miR-22/SIRT1 axis in acute myeloid leukemia apoptosis and response to chemotherapy. Leukemia. 38(8). 1764–1776. 10 indexed citations
4.
Casado, Pedro, Ana Rio‐Machín, Juho J. Miettinen, et al.. (2023). Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal Transduction and Targeted Therapy. 8(1). 80–80. 11 indexed citations
5.
Giotopoulos, George, Pedro Madrigal, Céline Philippe, et al.. (2023). Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death. Nature Communications. 14(1). 2132–2132. 11 indexed citations
6.
Hug, Nele, Stuart Aitken, Dáša Longman, et al.. (2022). A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation. RNA. 28(9). 1224–1238. 9 indexed citations
7.
Caye, Aurélie, Kevin Rouault‐Pierre, Marion Strullu, et al.. (2020). Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment. Leukemia. 34(7). 1973–1973. 1 indexed citations
8.
Waclawiczek, Alexander, Ashley Hamilton, Kevin Rouault‐Pierre, et al.. (2020). Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia. Journal of Clinical Investigation. 130(6). 3038–3050. 47 indexed citations
9.
Caye, Aurélie, Kevin Rouault‐Pierre, Marion Strullu, et al.. (2019). Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment. Leukemia. 34(6). 1658–1668. 11 indexed citations
10.
Abarrategi, Ander, Arántzazu Alfranca, Miguel Ángel Rodríguez-Milla, et al.. (2018). c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells. Scientific Reports. 8(1). 15615–15615. 13 indexed citations
11.
Passaro, Diana, Alessandro Di Tullio, Ander Abarrategi, et al.. (2017). Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia. Cancer Cell. 32(3). 324–341.e6. 164 indexed citations
12.
Tullio, Alessandro Di, et al.. (2017). Nuclear Factor Erythroid 2 Regulates Human HSC Self-Renewal and T Cell Differentiation by Preventing NOTCH1 Activation. Stem Cell Reports. 9(1). 5–11. 8 indexed citations
13.
Tullio, Alessandro Di, Kevin Rouault‐Pierre, Ander Abarrategi, et al.. (2017). The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia. Nature Communications. 8(1). 1679–1679. 40 indexed citations
14.
Rouault‐Pierre, Kevin, Syed A. Mian, Ander Abarrategi, et al.. (2017). Preclinical modeling of myelodysplastic syndromes. Leukemia. 31(12). 2702–2708. 24 indexed citations
15.
Passaro, Diana, Alessandro Di Tullio, Ander Abarrategi, et al.. (2016). Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Acute Myeloid Leukemia Progression and Drug Response. Blood. 128(22). 2662–2662. 3 indexed citations
16.
Rouault‐Pierre, Kevin, Ashley Hamilton, & Dominique Bonnet. (2015). Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact. Expert Opinion on Biological Therapy. 16(4). 463–476. 20 indexed citations
17.
Mian, Syed A., Kevin Rouault‐Pierre, Alexander Smith, et al.. (2015). SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment. Nature Communications. 6(1). 10004–10004. 62 indexed citations
18.
Foster, Katie, François Lassailly, Fernando Anjos‐Afonso, et al.. (2015). Different Motile Behaviors of Human Hematopoietic Stem versus Progenitor Cells at the Osteoblastic Niche. Stem Cell Reports. 5(5). 690–701. 17 indexed citations
19.
Pizzitola, Irene, Fernando Anjos‐Afonso, Kevin Rouault‐Pierre, et al.. (2014). Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo. Leukemia. 28(8). 1596–1605. 222 indexed citations
20.
Rouault‐Pierre, Kevin, Lourdes López-Onieva, Katie Foster, et al.. (2013). HIF-2α Protects Human Hematopoietic Stem/Progenitors and Acute Myeloid Leukemic Cells from Apoptosis Induced by Endoplasmic Reticulum Stress. Cell stem cell. 13(5). 549–563. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fotis Asimakopoulos Breakdown of academic impact, for papers by Keegan Barry-Holson Breakdown of academic impact, for papers by Frédéric Barabé Breakdown of academic impact, for papers by Enkhtsetseg Purev Breakdown of academic impact, for papers by Philippe Quittet Breakdown of academic impact, for papers by Jana Krošl Breakdown of academic impact, for papers by Catherine Frelin Breakdown of academic impact, for papers by Binje Vick Breakdown of academic impact, for papers by Francesco Paolo Tambaro Breakdown of academic impact, for papers by Allison Mayle
Rankless by CCL
2026